Harbin Pharmaceutical Group Co., Ltd.
600664Pharmaceuticals
CN¥5.29−2.94%As of Oct 29vs prior close
- Market cap
- $2B
- P/E (TTM)
- 21.2×
- P/E (FY1)
- 22.0×
- From 52W high
- −44.26%
- EPS (LTM)
- CN¥0.20
- Revenue (LTM)
- CN¥16.1B
- Net margin
- 3.89%
Nomior Score
52
Steady ProfileTop 47% of the scored universe
Growth43
Quality50
Value48
Momentum74
Resilience44
Growth
+4.95%revenue a year over 3 fiscal years
YE22 CN¥13.8BLTM CN¥16.1B
Connections
Revenue to profitYE25
2% of revenue became net profit, down 2 pts on a year.